Table 1 Final models, ID cohort (RR with 90% CI, bold marks statistically significance on the 10% level, NI = not included in the model)
Unplanned health care | Planned health care | ||||
|---|---|---|---|---|---|
Inpatient | Outpatient | Inpatient | Outpatient | ||
Demographics | |||||
50–59 vs < 50 years | 0.84 (0.70–1.02) | 0.88 (0.68–1.14) | 0.66 (0.46–0.95) | 1.04 (0.92–1.16) | |
60–69 vs < 50 years | 0.49 (0.38–0.62) | 0.54 (0.40–0.73) | 0.43 (0.28–0.66) | 0.83 (0.73–0.94) | |
70–79 vs < 50 years | 0.24 (0.16–0.36) | 0.23 (0.14–0.37) | 0.26 (0.13–0.52) | 0.53 (0.43–0.65) | |
80+ vs < 50 years | 0.12 (0.04–0.38) | 0.09 (0.02–0.45) | 0.17 (0.04–0.78) | 0.31 (0.18–0.54) | |
Men vs women | 0.91 (0.79–1.06) | 1.04 (0.88–1.23) | 0.88 (0.68–1.14) | 0.97 (0.90–1.03) | |
Diagnoses | |||||
E70-E90: Metabolic disorders | NI | NI | 2.37 (1.06–5.29) | 0.65 (0.37–1.15) | |
F00-F09: Organic, including symptomatic, mental disorders | 1.28 (0.90–1.81) | 1.59 (1.04–2.42) | 1.79 (1.05–3.06) | 1.51 (1.33–1.71) | |
F10-F19: Mental and behavioral disorders due to psychoactive substance use | 2.31 (1.66–3.21) | 3.12 (2.16–4.51) | 1.56 (0.98–2.50) | NI | |
F20-F29: Schizophrenia, schizotypal and delusional disorders | 1.73 (1.35–2.21) | 2.00 (1.46–2.75) | 2.11 (1.38–3.23) | 1.83 (1.63–2.05) | |
F30-F39: Mood [affective] disorders | 2.15 (1.69–2.74) | 2.30 (1.76–3.01) | 1.56 (1.03–2.36) | 1.82 (1.64–2.01) | |
F40-F48: Neurotic, stress-related and somatoform disorders | 2.03 (1.57–2.61) | 2.11 (1.52–2.93) | 1.88 (1.25–2.83) | 1.35 (1.22–1.50) | |
F60-F69: Disorders of adult personality and behavior | NI | NI | NI | 1.19 (1.01–1.41) | |
F80-F89: Disorders of psychological development | 1.78 (1.33–2.39) | 1.79 (1.21–2.67) | NI | 1.24 (1.06–1.46) | |
F90-F98: Behavioral and emotional disorders with onset usually occurring in childhood and adolescence | NI | NI | NI | 1.19 (1.03–1.38) | |
G40-G47: Episodic and paroxysmal disorders | 1.25 (0.95–1.65) | 1.28 (0.80–2.05) | 1.87 (1.17–2.99) | 1.26 (1.08–1.46) | |
G80-G83: Cerebral palsy and other paralytic syndromes | 1.85 (0.74–4.66) | NI | NI | 0.82 (0.60–1.13) | |
I10-I15: Hypertensive diseases | 2.39 (1.30–4.38) | 2.87 (1.13–7.30) | 2.07 (0.80–5.36) | NI | |
R10-R19: Symptoms and signs involving the digestive system and abdomen | NI | NI | NI | 0.95 (0.66–1.38) | |
R40-R46: Symptoms and signs involving cognition, perception, emotional state and behavior | NI | NI | 0.96 (0.54–1.72) | NI | |
Health care utilization previous year | |||||
Unplanned inpatient | 1 vs 0 | 9.43 (7.06–12.59) | 2.14 (1.55–2.96) | 6.98 (4.45–10.95) | 1.27 (1.13–1.43) |
2+ vs 0 | 11.45 (8.14–16.11) | 1.59 (1.05–2.39) | 6.54 (3.86–11.09) | 1.04 (0.88–1.22) | |
Unplanned outpatient | 1 vs 0 | 1.30 (1.00–1.68) | 4.65 (3.43–6.31) | 2.21 (1.39–3.51) | 1.33 (1.16–1.52) |
2–5 vs 0 | 1.05 (0.78–1.40) | 4.19 (2.87–6.11) | 1.83 (1.16–2.90) | 1.24 (1.05–1.46) | |
6+ vs 0 | 1.00 (0.53–1.91) | 5.55 (2.60–11.84) | 3.07 (1.36–6.91) | 0.98 (0.65–1.46) | |
Planned inpatient | 1 vs 0 | 2.17 (1.68–2.79) | 1.92 (1.34–2.75) | 8.03 (4.91–13.13) | 1.42 (1.20–1.69) |
2+ vs 0 | 1.74 (1.17–2.60) | 1.82 (1.18–2.82) | 7.37 (4.25–12.76) | 1.21 (0.91–1.62) | |
Planned outpatient | 1 vs 0 | 2.06 (1.63–2.61) | 3.09 (2.30–4.15) | 1.76 (1.23–2.53) | 14.06 (12.48–15.84) |
2–5 vs 0 | 1.72 (1.31–2.27) | 2.22 (1.57–3.14) | 1.74 (1.14–2.66) | 15.27 (13.33–17.49) | |
6+ vs 0 | 1.75 (1.15–2.64) | 2.20 (1.30–3.72) | 1.50 (0.90–2.50) | 14.85 (12.14–18.15) | |